RYM
RYM
RYTHM, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $10.66M ▲ | $8.16M ▼ | $-13.61M ▼ | -127.64% ▲ | $-6.62 ▼ | $-552K ▲ |
| Q3-2025 | $4.04M ▲ | $8.47M ▲ | $-10.66M ▼ | -263.79% ▲ | $-5.33 ▼ | $-7.7M ▼ |
| Q2-2025 | $2.04M ▲ | $7.48M ▲ | $-7.36M ▼ | -360.43% ▼ | $-3.73 ▼ | $-6.51M ▼ |
| Q1-2025 | $538K ▼ | $3.79M ▼ | $-1.63M ▲ | -302.23% ▲ | $-0.83 ▲ | $-2.94M ▲ |
| Q4-2024 | $2.15M | $7.47M | $-24.36M | -1.13K% | $-6.39 | $-10.57M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $32.22M ▼ | $106.68M ▼ | $93.66M ▼ | $13.02M ▲ |
| Q3-2025 | $35.57M ▼ | $115.15M ▲ | $103.43M ▲ | $11.72M ▼ |
| Q2-2025 | $40.96M ▲ | $69.47M ▲ | $48.51M ▲ | $20.96M ▼ |
| Q1-2025 | $24.45M ▼ | $45.62M ▼ | $18.8M ▼ | $26.82M ▼ |
| Q4-2024 | $31.17M | $54.02M | $25.93M | $27.86M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-13.61M ▼ | $-3.02M ▲ | $-5.08M ▲ | $-337K ▼ | $-3.35M ▲ | $-8.09M ▼ |
| Q3-2025 | $-10.63M ▼ | $-5.38M ▲ | $-50M ▼ | $50M ▲ | $-5.38M ▼ | $-5.38M ▲ |
| Q2-2025 | $-7.21M ▼ | $-8.42M ▼ | $-5.08M ▼ | $30M ▲ | $16.51M ▲ | $-8.42M ▼ |
| Q1-2025 | $-1.63M ▲ | $-6.72M ▼ | $0 ▲ | $-1K ▼ | $-6.72M ▼ | $-6.72M ▼ |
| Q4-2024 | $-24.36M | $-5.33M | $-394K | $36.63M | $30.91M | $-5.34M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|
License | $0 ▲ | $0 ▲ | $10.00M ▲ |
Royalty | $0 ▲ | $0 ▲ | $0 ▲ |
Q3 2022 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at RYTHM, Inc.'s financial evolution and strategic trajectory over the past five years.
RYM combines a developing revenue base and strong product‑level margins with a portfolio of recognizable cannabis and hemp brands, an asset‑light operating model, and a solid—though not abundant—cash balance. Its focus on effects‑based formulations, premium taste, and savvy partnerships gives it a differentiated foothold in the fast‑growing THC beverage and edibles segments, while licensing arrangements expand reach without heavy capital outlays.
The main concerns are financial and regulatory. The company is incurring deep operating and net losses and burning cash, while carrying meaningful short‑term debt and only a thin equity buffer. A large part of its asset value is tied up in intangibles that depend on brand performance. At the same time, it operates in a volatile, competitive, and politically sensitive regulatory environment, and it relies on partners for production and distribution—any misstep in these areas could quickly pressure both operations and the balance sheet.
RYM’s future hinges on whether it can translate its brand strength, product innovation, and distribution footprint into much better operating leverage and positive cash generation before its financial flexibility tightens. If revenue scales and costs are brought closer in line, the asset‑light, brand‑driven strategy could support a healthier profile over time. If not, continued losses, leverage, and regulatory uncertainty will remain significant overhangs. The trajectory from here will largely depend on execution discipline and how the regulatory and competitive landscapes evolve over the next few years.
About RYTHM, Inc.
https://agrify.comRYTHM, Inc. provides solutions for the cannabis and hemp industry in the United States. It offers consumers hemp-derived tetrahydrocannabinol beverages under the Señorita brand name. The company was formerly known as Agrify Corporation and changed its name to Agrify Corporation RYTHM, Inc. in August 2025. RYTHM, Inc. was incorporated in 2016 and is headquartered in Troy, Michigan.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $10.66M ▲ | $8.16M ▼ | $-13.61M ▼ | -127.64% ▲ | $-6.62 ▼ | $-552K ▲ |
| Q3-2025 | $4.04M ▲ | $8.47M ▲ | $-10.66M ▼ | -263.79% ▲ | $-5.33 ▼ | $-7.7M ▼ |
| Q2-2025 | $2.04M ▲ | $7.48M ▲ | $-7.36M ▼ | -360.43% ▼ | $-3.73 ▼ | $-6.51M ▼ |
| Q1-2025 | $538K ▼ | $3.79M ▼ | $-1.63M ▲ | -302.23% ▲ | $-0.83 ▲ | $-2.94M ▲ |
| Q4-2024 | $2.15M | $7.47M | $-24.36M | -1.13K% | $-6.39 | $-10.57M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $32.22M ▼ | $106.68M ▼ | $93.66M ▼ | $13.02M ▲ |
| Q3-2025 | $35.57M ▼ | $115.15M ▲ | $103.43M ▲ | $11.72M ▼ |
| Q2-2025 | $40.96M ▲ | $69.47M ▲ | $48.51M ▲ | $20.96M ▼ |
| Q1-2025 | $24.45M ▼ | $45.62M ▼ | $18.8M ▼ | $26.82M ▼ |
| Q4-2024 | $31.17M | $54.02M | $25.93M | $27.86M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-13.61M ▼ | $-3.02M ▲ | $-5.08M ▲ | $-337K ▼ | $-3.35M ▲ | $-8.09M ▼ |
| Q3-2025 | $-10.63M ▼ | $-5.38M ▲ | $-50M ▼ | $50M ▲ | $-5.38M ▼ | $-5.38M ▲ |
| Q2-2025 | $-7.21M ▼ | $-8.42M ▼ | $-5.08M ▼ | $30M ▲ | $16.51M ▲ | $-8.42M ▼ |
| Q1-2025 | $-1.63M ▲ | $-6.72M ▼ | $0 ▲ | $-1K ▼ | $-6.72M ▼ | $-6.72M ▼ |
| Q4-2024 | $-24.36M | $-5.33M | $-394K | $36.63M | $30.91M | $-5.34M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|
License | $0 ▲ | $0 ▲ | $10.00M ▲ |
Royalty | $0 ▲ | $0 ▲ | $0 ▲ |
Q3 2022 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at RYTHM, Inc.'s financial evolution and strategic trajectory over the past five years.
RYM combines a developing revenue base and strong product‑level margins with a portfolio of recognizable cannabis and hemp brands, an asset‑light operating model, and a solid—though not abundant—cash balance. Its focus on effects‑based formulations, premium taste, and savvy partnerships gives it a differentiated foothold in the fast‑growing THC beverage and edibles segments, while licensing arrangements expand reach without heavy capital outlays.
The main concerns are financial and regulatory. The company is incurring deep operating and net losses and burning cash, while carrying meaningful short‑term debt and only a thin equity buffer. A large part of its asset value is tied up in intangibles that depend on brand performance. At the same time, it operates in a volatile, competitive, and politically sensitive regulatory environment, and it relies on partners for production and distribution—any misstep in these areas could quickly pressure both operations and the balance sheet.
RYM’s future hinges on whether it can translate its brand strength, product innovation, and distribution footprint into much better operating leverage and positive cash generation before its financial flexibility tightens. If revenue scales and costs are brought closer in line, the asset‑light, brand‑driven strategy could support a healthier profile over time. If not, continued losses, leverage, and regulatory uncertainty will remain significant overhangs. The trajectory from here will largely depend on execution discipline and how the regulatory and competitive landscapes evolve over the next few years.

CEO
Benjamin Kovler
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-07-05 | Reverse | 1:20 |
| 2022-10-18 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 3 of 16
Ratings Snapshot
Rating : D+

